Zonisamide attenuates MPP+-induced oxidative toxicity through modulation of Ca2+ signaling and caspase-3 activity in neuronal PC12 cells.
about
Glia and TRPM2 Channels in Plasticity of Central Nervous System and Alzheimer's DiseasesIdentification of licopyranocoumarin and glycyrurol from herbal medicines as neuroprotective compounds for Parkinson's diseaseT-type calcium channel blockers as neuroprotective agents.Characterization of polyethylene glycol-polyethyleneimine as a vector for alpha-synuclein siRNA delivery to PC12 cells for Parkinson's disease.High Glucose-Induced PC12 Cell Death by Increasing Glutamate Production and Decreasing Methyl Group Metabolism.Zonisamide: a review of the clinical and experimental evidence for its use in Parkinson's diseasePathogenesis-targeted, disease-modifying therapies in Parkinson disease.Zonisamide-loaded triblock copolymer nanomicelles as a novel drug delivery system for the treatment of acute spinal cord injuryEffects of antiepileptic drugs on antioxidant and oxidant molecular pathways: focus on trace elements.The ongoing pursuit of neuroprotective therapies in Parkinson disease.Neuroprotection as a Potential Therapeutic Perspective in Neurodegenerative Diseases: Focus on Antiepileptic Drugs.Elevated hydrostatic pressures induce apoptosis and oxidative stress through mitochondrial membrane depolarization in PC12 neuronal cells: A cell culture model of glaucoma.Protective effects of zonisamide against rotenone-induced neurotoxicity.Curcumin inhibits apoptosis by regulating intracellular calcium release, reactive oxygen species and mitochondrial depolarization levels in SH-SY5Y neuronal cells.Neurotoxin mechanisms and processes relevant to Parkinson's disease: an update.Involvement of NF kappa B in potentiated effect of Mn-containing dithiocarbamates on MPP(+) induced cell death.
P2860
Q26768288-40AC58EA-D275-40A6-9722-3698E803C054Q28539943-94D95236-9B6D-47A0-AEC8-0095A9161379Q30415535-0E3CBFE9-B857-4932-B82F-252ABBD149ADQ35054395-2BEE236A-2651-486B-8803-435570351B66Q37060029-632E0283-83BA-44C9-833D-15AE3082BFAFQ37356891-1943A337-6788-4C11-B0B1-4AEB02822F9FQ37506492-FCAE96F2-D9AC-4B6C-A2EB-4CF0F017E22CQ37739993-0DBC8235-4F2F-4395-AED0-4FD3F48D4B66Q38098898-B79872BE-5E1D-4F1A-B766-E9EEC07634C1Q38275171-D720BB8D-D175-4704-8053-36D53FC736A4Q38684428-720D5068-FBEE-48FC-BA15-B90FF48261EFQ38997178-17F9F729-7032-44FB-9614-E95F0B1AC7BBQ39076196-47A078FE-A2CC-4AE3-A6D4-ADFC911C335BQ40273636-2A9CBDA7-C0A1-4997-8AA2-6CE3C2FDF2ACQ43679571-9495CD18-C1E5-46FD-962B-72D232874ACFQ44441304-E8758ACD-CD75-4E50-B73D-213A6BE189EB
P2860
Zonisamide attenuates MPP+-induced oxidative toxicity through modulation of Ca2+ signaling and caspase-3 activity in neuronal PC12 cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Zonisamide attenuates MPP+-ind ...... tivity in neuronal PC12 cells.
@en
Zonisamide attenuates MPP+-ind ...... tivity in neuronal PC12 cells.
@nl
type
label
Zonisamide attenuates MPP+-ind ...... tivity in neuronal PC12 cells.
@en
Zonisamide attenuates MPP+-ind ...... tivity in neuronal PC12 cells.
@nl
prefLabel
Zonisamide attenuates MPP+-ind ...... tivity in neuronal PC12 cells.
@en
Zonisamide attenuates MPP+-ind ...... tivity in neuronal PC12 cells.
@nl
P2093
P2860
P1476
Zonisamide attenuates MPP+-ind ...... tivity in neuronal PC12 cells.
@en
P2093
Abdülhadi Cihangir Uğuz
Hasan Rifat Koyuncuoğlu
Mustafa Nazıroğlu
Semih Gürler
Vedat Ali Yürekli
P2860
P2888
P304
P356
10.1007/S10571-012-9886-3
P577
2012-11-15T00:00:00Z